Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-01

FDA Approved: LIOMNY — Supplemental Application (SIGMAPHARM LABORATORIES, LLC)

View source ↗

Summary

FDA approved a supplemental application for LIOMNY (liothyronine sodium) from SigmaPharm Laboratories LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LIOMNY (LIOTHYRONINE SODIUM)

Snippet

SUPPL AP for LIOMNY (LIOTHYRONINE SODIUM)